Medline (MDLN) Cash from Financing Activities (2025 - 2026)

Medline (MDLN) reported Cash from Financing Activities of -$13.0 million for Q1 2026, down 44.44% year-over-year from -$23.4 million in Q1 2025, and down 44.44% on a QoQ basis from -$9.0 million in Q1 2025.

Medline (MDLN) has 2 years of Cash from Financing Activities data on file, last reported at -$13.0 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Intuitive Surgical 146.28 Bn 141.88 Bn 1.83 Bn -1.35 Bn
2 Becton Dickinson 41.14 Bn 40.13 Bn 2.15 Bn -414.00 Mn
3 Medline 29.16 Bn 35.00 Bn 1.84 Bn -13.00 Mn
4 Resmed 27.13 Bn 25.47 Bn 890.98 Mn -255.24 Mn
5 West Pharmaceutical Services 22.71 Bn 22.19 Bn 296.40 Mn -308.70 Mn
6 Solventum 13.26 Bn 13.26 Bn 1.10 Bn -50.00 Mn
7 Align Technology 12.22 Bn 11.16 Bn 736.59 Mn -48.13 Mn
8 Cooper Companies 11.79 Bn 11.66 Bn 695.20 Mn -147.90 Mn
9 Baxter International 9.47 Bn 7.42 Bn 891.00 Mn -11.00 Mn
10 Aptargroup 7.19 Bn 6.99 Bn 351.91 Mn -230.34 Mn

Historic Data

Download Data 🔒
DateValue
Mar 28, 2026 -13.00 Mn
Mar 28, 2026 -13.00 Mn
Mar 29, 2025 -9.00 Mn
Mar 29, 2025 -9.00 Mn